Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
186 hedge funds and large institutions have $541M invested in Meridian Bioscience Inc in 2018 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 68 increasing their positions, 57 reducing their positions, and 17 closing their positions.
81% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $581K
59% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 17
19% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 57
4% more funds holding
Funds holding: 178 → 186 (+8)
0% more capital invested
Capital invested by funds: $539M → $541M (+$1.72M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$6.27M |
| 2 |
Rafferty Asset Management
New York
|
+$4.62M |
| 3 |
Renaissance Technologies
New York
|
+$2.67M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$2.43M |
| 5 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$1.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$9.72M |
| 2 |
New York State Common Retirement Fund
Albany,
New York
|
-$7.31M |
| 3 |
Millennium Management
New York
|
-$4.35M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.76M |
| 5 |
CEI
Clark Estates Inc
New York
|
-$3.18M |
VIVO Hedge Fund Activity: Q1 2018 in Review
186 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q1 2018, worth a combined $541M — up 0.32% from $539M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new VIVO positions and 17 closed out — a net gain of 10 holders — while 68 added to existing stakes and 57 trimmed.
The largest buyer was AJO LP, adding an estimated $6.27M. The largest seller was Brown Capital Management, cutting an estimated $9.72M.
- 186 institutional investors held Meridian Bioscience Inc (VIVO) as of Q1 2018, up from 178 in Q4 2017.
- Funds reported $541M of Meridian Bioscience Inc stock for Q1 2018, up 0.32% quarter-over-quarter.
- 27 funds opened new Meridian Bioscience Inc positions in Q1 2018 and 17 closed out, a net change of +10 holders.
- The largest Meridian Bioscience Inc buyer in Q1 2018 was AJO LP, an estimated $6.27M added.
- The largest Meridian Bioscience Inc seller in Q1 2018 was Brown Capital Management, an estimated $9.72M sold.
Based on aggregated 13F filings for Q1 2018.